Add like
Add dislike
Add to saved papers

Prospective outcome study of 360 patients treated with liposuction, lipoabdominoplasty, and abdominoplasty.

BACKGROUND: Patient-reported data, including effects on quality of life, have not been previously prospectively evaluated in liposuction patients, or in abdominoplasty patients treated simultaneously with liposuction. This prospective outcome study was undertaken to evaluate and compare liposuction and abdominoplasty from the patient's perspective.

METHODS: From 2002 to 2007, in-person interviews were conducted with 360 patients who attended a follow-up appointment at least 1 month after surgery, from a total of 551 consecutive patients treated with ultrasonic liposuction and/or abdominoplasty (response rate, 65.3 percent). Questions were asked in six categories: patient data, indications, recovery, results, complications, and psychological effects. Responses were analyzed in three groups: liposuction alone (n = 219), combined liposuction and abdominoplasty (n = 128), and abdominoplasty alone (n = 13).

RESULTS: For most recovery indices, liposuction patients recovered significantly more quickly than lipoabdominoplasty patients (p ≤ 0.01) and had less discomfort (pain ratings, 6.1 of 10 and 7.5 of 10, respectively; p < 0.001). The result ratings for lipoabdominoplasty (9.0 of 10) and abdominoplasty (8.7 of 10) were higher than for liposuction alone (7.8 of 10; p < 0.001). Overall, 85.8 percent of patients reported improved self-esteem and 69.6 percent reported an improved quality of life.

CONCLUSIONS: : Liposuction and abdominoplasty, either alone or in combination, provide high levels of patient satisfaction (88.8 percent overall). The combined procedure is similar in discomfort level to abdominoplasty alone (both 7.5 of 10) and produces the highest level of patient satisfaction (99.2 percent), with 97.6 percent of patients saying they would undergo the operation again and 99.2 percent recommending it to others.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app